Amendment #2 Cooperative Research and Development Agreement # 03111Ziopharm Oncology Inc • September 26th, 2019 • Pharmaceutical preparations
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR...Research and Development Agreement • September 26th, 2019 • Ziopharm Oncology Inc • Pharmaceutical preparations • District of Columbia
This Agreement is based on the model Cooperative Research and Development Agreement (“CRADA”) adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the National Institutes of Health (“NIH”), the Centers for Disease Control and Prevention (“CDC”), and the Food and Drug Administration (“FDA”), which are agencies of the PHS within the Department of Health and Human Services (“HHS”).
Amendment #1 Cooperative Research and Development Agreement # 03111Ziopharm Oncology Inc • September 26th, 2019 • Pharmaceutical preparations
